Javascript must be enabled to continue!
ROLE OF ASPIRIN AS PROPHYLAXIS AGAINST COLORECTAL CANCER
View through CrossRef
Introduction: Colorectal cancer (Bowel Cancer) is cancer of colon and rectum that are the parts of large intestine. [1] Symptoms are pain on defecation, blood and mucus in feces.[2] Risk factors of colon cancer are certain diet that is red meat, alcohol, and meat that is processed, obesity, smoking, and lack of physical activity.[3, 4]. Others factors are old age, type three personalities and usage of spicy foods. People with inflammatory bowel disease (ulcerative colitis and Crohn's disease), familial adenomatous polyposis are at high threat of cancer of colon and rectum. This can be prevented by using aspirin usage in long term.[5,6,7]. In high danger families, cancer of colon can be prevented by using aspirin and colonoscopies are recommended in these families.[8,9] Colorectal cancer can be diagnosed by sigmoidoscopy or colonoscopy.[10,11,12] .Most of people (50 %) do not report any signs and symptoms of colon cancer.[13,14]. Streptococcus gallolyticus is associated with colorectal cancer.[15, 16]
Objective: To find out the role of aspirin as prophylaxis against colorectal cancer.
Methodology: This descriptive retrospective study was conducted in the Ibnae –Sienna Hospital Multan from January 2016 to August 2017. 100 patients of each group between 50-65 years of age were included in the study; all were male whose were taken aspirin for pain killer and for fever as routine since long term and 100 male patients of same age not used aspirin. Date analysis was carried out using SPSS version 19 Software. Results: All were male patients 100 (100 %) 50-65 years of age. Most of the patients (98) 98 % who used aspirin in the past have no colorectal cancer as compared to patients (18) 18 % who not taken aspirin in the past have colorectal cancer.
Conclusion: Patients used aspirin since long have very least possibilities of colorectal cancer
Postgraduate Medical Institute, Lahore General Hospital
Title: ROLE OF ASPIRIN AS PROPHYLAXIS AGAINST COLORECTAL CANCER
Description:
Introduction: Colorectal cancer (Bowel Cancer) is cancer of colon and rectum that are the parts of large intestine.
[1] Symptoms are pain on defecation, blood and mucus in feces.
[2] Risk factors of colon cancer are certain diet that is red meat, alcohol, and meat that is processed, obesity, smoking, and lack of physical activity.
[3, 4].
Others factors are old age, type three personalities and usage of spicy foods.
People with inflammatory bowel disease (ulcerative colitis and Crohn's disease), familial adenomatous polyposis are at high threat of cancer of colon and rectum.
This can be prevented by using aspirin usage in long term.
[5,6,7].
In high danger families, cancer of colon can be prevented by using aspirin and colonoscopies are recommended in these families.
[8,9] Colorectal cancer can be diagnosed by sigmoidoscopy or colonoscopy.
[10,11,12] .
Most of people (50 %) do not report any signs and symptoms of colon cancer.
[13,14].
Streptococcus gallolyticus is associated with colorectal cancer.
[15, 16]
Objective: To find out the role of aspirin as prophylaxis against colorectal cancer.
Methodology: This descriptive retrospective study was conducted in the Ibnae –Sienna Hospital Multan from January 2016 to August 2017.
100 patients of each group between 50-65 years of age were included in the study; all were male whose were taken aspirin for pain killer and for fever as routine since long term and 100 male patients of same age not used aspirin.
Date analysis was carried out using SPSS version 19 Software.
Results: All were male patients 100 (100 %) 50-65 years of age.
Most of the patients (98) 98 % who used aspirin in the past have no colorectal cancer as compared to patients (18) 18 % who not taken aspirin in the past have colorectal cancer.
Conclusion: Patients used aspirin since long have very least possibilities of colorectal cancer.
Related Results
Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival
Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival
Abstract
Compelling epidemiologic data, supported by experimental evidence, suggest aspirin may improve survival in breast cancer patients. However, recent clinical ...
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Aspirin, commonly used for prevention of cardiovascular and cerebrovascular diseases, has been found to possess protective effects against cancer development in the Western populat...
Abstract 793: NOSH-aspirin and 5-fluorouracil demonstrate synergistic efficacy in a xenograft model of colon cancer
Abstract 793: NOSH-aspirin and 5-fluorouracil demonstrate synergistic efficacy in a xenograft model of colon cancer
Abstract
Introduction: Work in cancer biology, epidemiology and preclinical models has made it clear that non-steroidal anti-inflammatory drugs (NSAIDs) in general a...
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Objective: To evaluate and provide management strategies for patients with aspirin or nonselective nonsteroidal antiinflammatory drug (NSAID) sensitivity. Data Sources: Literature ...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract
OBJECTIVE:
Colorectal cancer is a cancer with high prevalence and mortality rates worldwide, treated with surger...
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract 3681: Aspirin acetylates glucose 6 phosphate dehydrogenase and inhibits its activity in colon cancer cells.
Abstract
Epidemiological studies have demonstrated a significant correlation between regular aspirin use and reduced colon cancer incidence and mortality. Although a...

